These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 7585640

  • 1. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma.
    Törmänen U, Eerola AK, Rainio P, Vähäkangas K, Soini Y, Sormunen R, Bloigu R, Lehto VP, Pääkkö P.
    Cancer Res; 1995 Dec 01; 55(23):5595-602. PubMed ID: 7585640
    [Abstract] [Full Text] [Related]

  • 2. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 01; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 3. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000 May 01; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 4. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS, Srinivasan R, Wali A, Majumdar S, Joshi K, Behera D.
    Lung Cancer; 2004 Aug 01; 45(2):181-8. PubMed ID: 15246189
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan 01; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

  • 10. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
    Ferreira CG, van der Valk P, Span SW, Ludwig I, Smit EF, Kruyt FA, Pinedo HM, van Tinteren H, Giaccone G.
    Clin Cancer Res; 2001 Aug 01; 7(8):2468-74. PubMed ID: 11489828
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, Landreneau RJ.
    Cancer Res; 1997 Feb 01; 57(3):433-9. PubMed ID: 9012470
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Kakolyris S, Turley H, O'Byrne K, Scott PA, Pezzella F, Georgoulias V, Harris AL, Gatter KC.
    Clin Cancer Res; 1998 Dec 01; 4(12):3017-24. PubMed ID: 9865915
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
    Jäckel MC, Sellmann L, Dorudian MA, Youssef S, Füzesi L.
    Laryngoscope; 2000 Aug 01; 110(8):1339-45. PubMed ID: 10942137
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.